Visipaque

Visipaque (iodixanol) is a non-ionic, iso-osmolar contrast agent used in radiographic imaging. It enhances visibility of blood vessels and tissues during CT scans, MRIs, and angiographic procedures. Suitable for intraarterial, intravenous, and intrathecal administration. Designed for clear, high-contrast imaging with reduced risk of adverse reactions compared to ionic agents.

Visipaque (iodixanol) is commonly used in medical imaging to improve the visibility of blood vessels, organs, and tissues during diagnostic procedures. It is employed in CT angiography, cardiac catheterization, and peripheral arteriography to highlight vascular structures. The agent is also used in intrathecal imaging for spinal and cerebral studies, providing clear contrast for detailed anatomical assessment.

After administration, Visipaque (iodixanol) distributes rapidly in the bloodstream, enhancing the contrast of images captured during radiographic procedures. Patients may experience a transient warming sensation at the injection site or a metallic taste, which typically resolves quickly. The agent is designed to minimize discomfort while providing high-quality imaging results.

Visipaque (iodixanol) should be used with caution in patients with a history of severe allergic reactions to contrast media. Adequate hydration before and after administration is recommended to reduce the risk of kidney-related side effects. Healthcare providers should monitor patients for signs of hypersensitivity reactions during and after the procedure.

Visipaque (iodixanol) may interact with medications that affect kidney function, such as certain diuretics or nephrotoxic drugs. Patients taking metformin should temporarily discontinue its use before and after contrast administration to avoid potential lactic acidosis. Alcohol and other substances that impair kidney function may also increase the risk of adverse effects.